Market Cap 255.76M
Revenue (ttm) 341.92M
Net Income (ttm) 20.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 6.13%
Debt to Equity Ratio 0.00
Volume 3,341,100
Avg Vol 405,284
Day's Range N/A - N/A
Shares Out 46.84M
Stochastic %K 79%
Beta N/A
Analysts Sell
Price Target $10.50

Company Profile

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. It offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). The company also provides CapsoClou...

Industry: Medical Devices
Sector: Healthcare
Phone: 408 624 1488
Fax: 408 370 4795
Address:
18805 Cox Avenue, Suite 250, Saratoga, United States
StockScanners
StockScanners Mar. 21 at 1:29 AM
$CV keep watch if this holds above 6.59
0 · Reply
topstockalerts
topstockalerts Mar. 20 at 3:20 PM
$CV bigger name but still tradable on momentum shifts. Not as explosive but cleaner structure.
0 · Reply
FoxyDreams
FoxyDreams Mar. 20 at 2:00 PM
~@SqueezeSharkie is operating on a whole different level, easily ahead of 90% of traders on this platform. ~If you’re not following yet, you’re missing out. It takes 2 seconds and it’s completely free. 💎 $CV $KMRK $AIDX $ASBP * on close watch
0 · Reply
DonCorleone77
DonCorleone77 Mar. 20 at 12:17 PM
$CV CapsoVision announces $14M private placement financing CapsoVision "announced the closing of a $14 million private placement in public equity financing pursuant to a securities purchase agreement entered into by the company with selected accredited investors on March 16, 2026 for such investors to purchase shares of common stock of the company."
0 · Reply
DARKP00L
DARKP00L Mar. 20 at 12:05 PM
$CV 08:02 on Mar. 20 2026 CapsoVision Closes $14M Private Placement In Public Equity Financing #tradeideas
0 · Reply
FoxyDreams
FoxyDreams Mar. 20 at 2:43 AM
•@SqueezeSharkie is on another level, outperforming 90% of traders on this platform. •If you’re not following yet, you’re leaving value on the table. Takes 2 seconds and it’s free. 💎 ’ $WATT $CV $ERAS $TWO 0n watch
0 · Reply
niko5407
niko5407 Mar. 16 at 2:40 PM
$CV something brewing here
0 · Reply
niko5407
niko5407 Mar. 16 at 2:36 PM
$CV in
0 · Reply
focafoca99
focafoca99 Mar. 14 at 10:43 PM
$CV amended its original development agreement, so whatever they are building is still evolving in the real world.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 28 at 1:38 AM
$CV RSI: 58.36, MACD: -0.3633 Vol: 0.26, MA20: 4.98, MA50: 7.17 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StockScanners
StockScanners Mar. 21 at 1:29 AM
$CV keep watch if this holds above 6.59
0 · Reply
topstockalerts
topstockalerts Mar. 20 at 3:20 PM
$CV bigger name but still tradable on momentum shifts. Not as explosive but cleaner structure.
0 · Reply
FoxyDreams
FoxyDreams Mar. 20 at 2:00 PM
~@SqueezeSharkie is operating on a whole different level, easily ahead of 90% of traders on this platform. ~If you’re not following yet, you’re missing out. It takes 2 seconds and it’s completely free. 💎 $CV $KMRK $AIDX $ASBP * on close watch
0 · Reply
DonCorleone77
DonCorleone77 Mar. 20 at 12:17 PM
$CV CapsoVision announces $14M private placement financing CapsoVision "announced the closing of a $14 million private placement in public equity financing pursuant to a securities purchase agreement entered into by the company with selected accredited investors on March 16, 2026 for such investors to purchase shares of common stock of the company."
0 · Reply
DARKP00L
DARKP00L Mar. 20 at 12:05 PM
$CV 08:02 on Mar. 20 2026 CapsoVision Closes $14M Private Placement In Public Equity Financing #tradeideas
0 · Reply
FoxyDreams
FoxyDreams Mar. 20 at 2:43 AM
•@SqueezeSharkie is on another level, outperforming 90% of traders on this platform. •If you’re not following yet, you’re leaving value on the table. Takes 2 seconds and it’s free. 💎 ’ $WATT $CV $ERAS $TWO 0n watch
0 · Reply
niko5407
niko5407 Mar. 16 at 2:40 PM
$CV something brewing here
0 · Reply
niko5407
niko5407 Mar. 16 at 2:36 PM
$CV in
0 · Reply
focafoca99
focafoca99 Mar. 14 at 10:43 PM
$CV amended its original development agreement, so whatever they are building is still evolving in the real world.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 28 at 1:38 AM
$CV RSI: 58.36, MACD: -0.3633 Vol: 0.26, MA20: 4.98, MA50: 7.17 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
flowerchefstocks
flowerchefstocks Feb. 24 at 5:06 PM
$CV The pharmacy Benefit business has been a real problem and all the regulations coming down is a drag on revenues but I think no one is talking about the cost structure. There is a high percentage of cost in the verification process of a prescription. This all goes away if they move to a smart contract and start licensing this technology from $DVLT. This article just makes so much sense. If you cant beat up the drug companies anymore lower your cost structure to nothing using blockchain technology. It eliminates a ton of redundancies. https://www.zerohedge.com/news/2026-02-24/600-billion-prescription-drug-cartel-just-got-disrupted-and-two-small-cap-stocks
0 · Reply
FeliciaMath
FeliciaMath Jan. 26 at 7:29 PM
sold $CV today. break even.
0 · Reply
FeliciaMath
FeliciaMath Jan. 24 at 6:32 PM
losing patience with $CV. may sell next week
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 24 at 6:49 AM
$CV Current Stock Price: $6.00
0 · Reply
FeliciaMath
FeliciaMath Jan. 14 at 7:19 PM
bought $CV at 6.01
0 · Reply
REDBEAR
REDBEAR Jan. 13 at 6:41 PM
$CV stocktwits, wtf is this? fix it. i need to read the comments and ask if this is a good buy?
3 · Reply
garygb
garygb Jan. 11 at 3:03 PM
$CV This is having a bad year. Down and forgotten while sitting on the leading edge of ai in medicine. Best longshot I know of. Doubling down and holding tight.
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 5:37 PM
$CV is bringing AI into capsule endoscopy — and FDA is the next gate. CapsoVision has submitted an FDA 510(k) to add an AI-assisted reading module to CapsoCam Plus, aiming to boost diagnostic accuracy and streamline clinical reviews. 🧠⚕️ See why this AI upgrade could be a meaningful catalyst 👉 https://www.zacks.com/stock/news/2811389/capsovision-submits-fda-510k-for-ai-assisted-module-in-capsocam-plus?cid=sm-stocktwits-2-2811389-teaser-27207&ADID=SYND_STOCKTWITS_TWEET_2_2811389_TEASER_27207
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 4:17 PM
$CV drops 7.7% post-announcement — what’s behind the slide? 🤔 Despite a 205.4% surge over six months, the recent dip coincides with CV's FDA submission for an AI reading feature in its CapsoCam Plus system. This AI-enhancement aims to boost diagnostic accuracy and efficiency but needs clearance first. Full scoop here 👉 https://www.zacks.com/stock/news/2811389/capsovision-submits-fda-510k-for-ai-assisted-module-in-capsocam-plus?cid=sm-stocktwits-2-2811389-body-27182&ADID=SYND_STOCKTWITS_TWEET_2_2811389_BODY_27182
0 · Reply
medguy
medguy Jan. 1 at 12:12 AM
Looking for a bounce $AFJK $TRON $CV $CORT
0 · Reply
Easteregg
Easteregg Dec. 30 at 5:46 PM
$CV Does their technology have any advantage over the competition? Anyone knowledgeable about this company?
0 · Reply
topstockalerts
topstockalerts Dec. 29 at 1:58 PM
Pre Market Top Gainers PT2 $ANL $AFJK $SOPA $CV $BRLS
0 · Reply